WallStreetZenWallStreetZen

NASDAQ: RKDA
Arcadia Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RKDA past revenue growth

How has RKDA's revenue growth performed historically?
Company
-10.11%
Industry
15.96%
Market
13.96%
RKDA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RKDA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RKDA's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RKDA earnings and revenue history

Current Revenue
$8.2M
Current Earnings
-$20.3M
Current Profit Margin
-245.9%

RKDA Return on Equity

Current Company
-90.4%
Current Industry
13.3%
Current Market
30.8%
RKDA's Return on Equity (-90.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RKDA announces earnings.

RKDA Return on Assets

Current Company
-62.9%
Current Industry
9.2%
RKDA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RKDA Return on Capital Employed

Current Company
-78.85%
Current Industry
17%
RKDA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RKDA vs Agricultural Input Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RKDA$8.25M-$19.46M-$20.27M+20.67%N/A
SVFD$427.38k-$6.10M-$6.12M+142.56%N/A
YTEN$361.00k-$13.20M-$14.02M-11.90%N/A
SEED$7.80M$867.95k-$929.53k+123.51%N/A
CGA$132.51M-$16.24M-$17.16M-14.15%N/A
View Top Agricultural Input Stocks

Arcadia Biosciences Earnings & Revenue FAQ

What were RKDA's earnings last quarter?

On Invalid Date, Arcadia Biosciences (NASDAQ: RKDA) reported Q1 2023 earnings per share (EPS) of -$10.86, up 34.24% year over year. Total Arcadia Biosciences earnings for the quarter were -$9.38 million. In the same quarter last year, Arcadia Biosciences's earnings per share (EPS) was -$8.09.

If you're new to stock investing, here's how to buy Arcadia Biosciences stock.

What was RKDA's earnings growth in the past year?

As of Q2 2023, Arcadia Biosciences's earnings has grown year over year. Arcadia Biosciences's earnings in the past year totalled -$20.27 million.

What was RKDA's revenue last quarter?

On Invalid Date, Arcadia Biosciences (NASDAQ: RKDA) reported Q1 2023 revenue of $1.51 million up 53.14% year over year. In the same quarter last year, Arcadia Biosciences's revenue was $3.22 million.

What was RKDA's revenue growth in the past year?

As of Q2 2023, Arcadia Biosciences's revenue has grown -10.11% year over year. This is 26.07 percentage points lower than the US Agricultural Inputs industry revenue growth rate of 15.96%. Arcadia Biosciences's revenue in the past year totalled $8.25 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.